HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant production of a hybrid plasminogen activator composed of surfactant protein B and low-molecular-weight urokinase.

Abstract
Intraalveolar fibrin deposition is commonly observed during acute inflammatory and chronic interstitial lung diseases and may contribute to impairment of surfactant function and gas exchange. We recently described a chemically cross-linked chimeric protein consisting of surfactant protein (SP)-B and urokinase (uPA) for targeting alveolar fibrin under conditions such as acute respiratory distress syndrome (ARDS) or lung fibrosis. We now investigated the feasibility of a recombinant production of a fusion protein encoding mature SP-B and uPA, termed SPUC. Four different SPUC proteins (N-term SP-B/C-term uPA, N-term uPA/C-term SP-B, each +/- His-tag) were prepared by cloning the cDNA encoding mature SP-B and low-molecular-weight uPA into the expression vector pcDNA3.1. CHO-cells were transfected with the constructs and the supernatant and cell lysates were analyzed for expression of SPUC. Using a chromogenic substrate assay uPA activity was found in supernatants and lysates of transfected cells with highest activities related to the N-term uPA/C-term SP-B (+/- His-tag) construct in supernatants 48h after transfection. Casein enzymography showed an enzymatically active fusion proteins with a molecular weight of approximately 42 kDa in the supernatant of cells transfected with the N-term uPA/C-term SP-B (+/- His-tag) construct, but only a minor activity with the N-term SP-B/C-term uPA construct. The N-term uPA/C-term SP-B construct was also shown to possess higher resistance towards inhibition by plasminogen activator inhibitor-1. We conclude that recombinant production of a fusion protein consisting of mature SP-B and uPA is feasible, when the SP-B moiety is fused to the C-terminus of urokinase.
AuthorsClemens Ruppert, Poornima Mahavadi, Malgorzata Wygrecka, Timothy E Weaver, Viktor Magdolen, Steven Idell, Klaus T Preissner, Werner Seeger, Andreas Günther, Philipp Markart
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 100 Issue 6 Pg. 1185-92 (Dec 2008) ISSN: 0340-6245 [Print] Germany
PMID19132247 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Caseins
  • Plasminogen Activator Inhibitor 1
  • Pulmonary Surfactant-Associated Protein B
  • Recombinant Fusion Proteins
  • Urokinase-Type Plasminogen Activator
Topics
  • Animals
  • Blotting, Western
  • CHO Cells
  • Caseins (metabolism)
  • Cell Survival
  • Cloning, Molecular
  • Cricetinae
  • Cricetulus
  • Feasibility Studies
  • Gene Expression
  • Humans
  • Molecular Weight
  • Plasminogen Activator Inhibitor 1 (metabolism)
  • Protein Structure, Tertiary
  • Pulmonary Surfactant-Associated Protein B (biosynthesis, genetics)
  • Recombinant Fusion Proteins (biosynthesis)
  • Time Factors
  • Transfection
  • Urokinase-Type Plasminogen Activator (biosynthesis, chemistry, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: